Pubblicazioni scientifiche

Anno: 2021

  1. Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia
    Pubblicato su: European Journal of Medicinal Chemistry
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
  2. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme
    Pubblicato su: European Journal of Pharmacology
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
    - Vedi su: 'PubMed'

Anno: 2020

  1. Sulfonamide Inhibitors of β-Catenin Signaling as Anticancer Agents with Different Output on c-MYC
    Pubblicato su: ChemMedChem
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
  2. Discovery of Zika Virus NS2B/NS3 Inhibitors That Prevent Mice from Life-Threatening Infection and Brain Damage
    Pubblicato su: ACS Medicinal Chemistry Letters
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
  3. Discovery of New 1,1′-Biphenyl-4-sulfonamides as Selective Subnanomolar Human Carbonic Anhydrase II Inhibitors
    Pubblicato su: ACS Medicinal Chemistry Letters
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
  4. Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
    Pubblicato su: Journal of Computer-Aided Molecular Design
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
  5. New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains
    Pubblicato su: European Journal of Medicinal Chemistry
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
  6. Discovery of kynurenines containing oligopeptides as potent opioid receptor agonists
    Pubblicato su: Biomolecules
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'
    - Vedi su: 'PubMed'

Anno: 2019

  1. Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents
    Pubblicato su: ACS Medicinal Chemistry Letters
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'

Anno: 2018

  1. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors
    Pubblicato su: European Journal of Medicinal Chemistry
    - Vedi su: 'Scopus'
    - Vedi su: 'ScienceDirect'

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma